Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FENC Fennec Pharmaceuticals Inc.

已收盘 11-22 16:00:00 EST

5.32

+0.60

+12.71%

盘后5.32

+0.000.00%

17:58 EST

最高5.55	最低4.68	成交量37.19万
今开4.68	昨收4.72	日振幅18.43%
总市值1.46亿	流通市值6,952万	总股本2,743万
成交额197.15万	换手率2.85%	流通股本1,307万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"FENC","market":"US","secType":"STK","nameCN":"Fennec Pharmaceuticals Inc.","latestPrice":5.32,"timestamp":1732309200000,"preClose":4.72,"halted":0,"volume":371880,"hourTrading":{"tag":"盘后","latestPrice":5.32,"preClose":5.32,"latestTime":"17:58 EST","volume":875,"amount":4654.94,"timestamp":1732316337068},"delay":0,"floatShares":13067783,"shares":27432234,"eps":-0.041639,"marketStatus":"已收盘","marketStatusCode":5,"change":0.6,"latestTime":"11-22 16:00:00 EST","open":4.68,"high":5.55,"low":4.68,"amount":1971498.540312,"amplitude":0.184322,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.041639,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":4.72,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":5.32,"preClose":5.32,"latestTime":"17:58 EST","volume":875,"amount":4654.94,"timestamp":1732316337068},"volumeRatio":2.533394,"impliedVol":0.4292,"impliedVolPercentile":0.246},"requestUrl":"/m/hq/s/FENC","defaultTab":"news","newsList":[{"id":"2484148403","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148403?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:59","pubTimestamp":1732114756,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时59分，Fennec Pharmaceuticals Inc.股票出现异动，股价大幅拉升5.03%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为933.70%、416.57%、167.47%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Jasper Therapeutics Inc C/Wts 24/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为183.66%、102.78%、65.87%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225916abd23fb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225916abd23fb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2484960389","title":"美国研究综述-Equifax、Microstrategy、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484960389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484960389?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000212,"startTime":"0","endTime":"0","summary":"美国研究综述-Equifax、Microstrategy、Netflix路透11月19日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Equifax、Microstrategy 和 Netflix。要闻  * 凯斯百货公司CASY.O：杰富瑞将目标价从 450 美元上调至 470 美元 * Equifax Inc EFX.N：摩根大通将目标价从304美元下调至283美元 * Microstrategy Inc MSTR.O：Benchmark将目标价从300美元上调至450美元 * Netflix Inc NFLX.O：杰富瑞将目标价从800美元上调至1000美元 * Palo Alto Networks Inc PANW.O：杰富瑞将目标价从400美元上调至450美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LOVE","LU1670710661.SGD","LU0109394709.USD","LU1046421795.USD","LU1429558221.USD","KMPR","BK4585","CCCC","KHC","CASY","ACRS","MEOH","MOS","RDDT","WSM","BK4077","CGEM","FNV","LU2326559502.SGD","ARVN","CHPT","PANW","BK4588","MSTR","NFLX","PLUG","VRT","BK4113","LU1571399168.USD","MRNA","CPRT","RGNX","PTCT","FTNT","EHAB","CPRX","KYMR","BECN","QS","LU2249611893.SGD","FENC","LU0106261372.USD","RC","EFX","IDYA","DCOM","LU2237957902.USD","BK4107","IE00BQXX3C00.GBP"],"gpt_icon":1},{"id":"2484854813","title":"Fennec Pharmaceuticals Inc.2024财年第三财季实现净利润-5.74百万美元，同比减少206.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484854813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484854813?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731772991,"startTime":"0","endTime":"0","summary":"11月17日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2024财年第三财季净利润为-5.74百万美元，同比减少206.95%；其中营业收入为6.97百万美元，同比增加6.90%，每股基本收益为-0.21美元。机构评级：截至2024年11月17日，当前有4家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为13.25美元，其中最低目标价为12.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000416abc79099&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000416abc79099&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2483396378","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483396378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483396378?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:29","pubTimestamp":1731515396,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时29分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅上涨5.44%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为481.74%、286.13%、103.74%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为88.00%、67.77%、46.01%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002956a2349b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114002956a2349b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2481198320","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘大幅上涨5.00%报5.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481198320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481198320?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:30","pubTimestamp":1730903428,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时30分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报5.04美元/股，成交量363股，换手率0.00%，振幅0.00%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Macrogenics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Syndax Pharmaceuticals, Inc.涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1007.84%、97.66%、46.60%，振幅较大的相关个股有Nurix Therapeutics, Inc.、Ocular Therapeutix, Inc.、诺瓦瓦克斯医药，振幅分别为104.05%、103.88%、96.82%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622302898e40d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622302898e40d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2481536522","title":"Fennec Pharmaceuticals Inc.盘中异动 临近午盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481536522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481536522?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:33","pubTimestamp":1730738004,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时33分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速上涨5.07%。截至发稿，该股报4.56美元/股，成交量2.4769万股，换手率0.09%，振幅6.22%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为322.05%、272.26%、73.27%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003324971a4372&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105003324971a4372&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2480881599","title":"Fennec Pharmaceuticals Inc   预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881599","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881599?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:00","pubTimestamp":1730469651,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    将于11月7日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的618万美元增长42.6%，达到882.1万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期是每股亏损 10 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 15.00 美元，高于其最新收盘价 4.36 美元。11月1日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Fennec Pharmaceuticals Inc   预计每股亏损 10 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2478486244","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅上涨7.55%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486244?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:36","pubTimestamp":1730122617,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时36分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升7.55%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Monte Rosa Therapeutics, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为549.74%、48.81%、37.01%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monopar Therapeutics Inc.、Calidi Biotherapeutics, Inc.，振幅分别为34.60%、18.55%、18.35%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821365798e3ed05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821365798e3ed05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2478196513","title":"Fennec Pharmaceuticals Inc.盘中异动 快速下跌5.24%报4.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478196513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478196513?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:38","pubTimestamp":1729885090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时38分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速跳水5.24%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为866.68%、793.64%、434.91%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026033810ab74a1c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026033810ab74a1c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2474208488","title":"Fennec Pharmaceuticals Inc.盘中异动 下午盘大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474208488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474208488?lang=zh_cn&edition=full","pubTime":"2024-10-10 02:50","pubTimestamp":1728499832,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日02时50分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.10%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Nutriband Inc C/Wts 、Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为725.51%、551.26%、249.20%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101002503398e3b860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101002503398e3b860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2472334642","title":"Fennec Pharmaceuticals Inc.盘中异动 下午盘股价大跌5.00%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472334642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472334642?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:39","pubTimestamp":1727717949,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时39分，Fennec Pharmaceuticals Inc.股票出现波动，股价急速下挫5.00%。截至发稿，该股报4.94美元/股，成交量1.7101万股，换手率0.06%，振幅4.53%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001013910ab672fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001013910ab672fe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2470769987","title":"Fennec Pharmaceuticals Inc.盘中异动 下午盘急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470769987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470769987?lang=zh_cn&edition=full","pubTime":"2024-09-27 03:00","pubTimestamp":1727377220,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日03时00分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅拉升5.36%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Pasithea Therapeutics Corp.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Pasithea Therapeutics Corp.、Nucana Plc、Kintara Therapeutics, Inc.较为活跃，换手率分别为5302.15%、178.28%、115.45%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp.，振幅分别为79.84%、75.67%、54.10%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927030021ab663a90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927030021ab663a90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2460503422","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460503422","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460503422?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:31","pubTimestamp":1724074288,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时31分，Fennec Pharmaceuticals Inc.股票出现波动，股价大幅下挫5.22%。截至发稿，该股报5.27美元/股，成交量8245股，换手率0.03%，振幅4.50%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Cingulate Inc.较为活跃，换手率分别为1882.53%、1334.79%、295.45%，振幅较大的相关个股有Virax Biolabs Group Limited、Theriva Biologics, Inc.、Alzamend Neuro, Inc.，振幅分别为34.74%、31.36%、24.51%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921312898e35566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921312898e35566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2460837710","title":"Fennec Pharmaceuticals Inc.2024财年第二财季实现净利润-5.55百万美元，同比减少2.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460837710","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460837710?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:04","pubTimestamp":1723997066,"startTime":"0","endTime":"0","summary":"8月19日，Fennec Pharmaceuticals Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.55百万美元，同比减少2.02%；其中营业收入为7.26百万美元，同比增加118.02%，每股基本收益为-0.20美元。机构评级：截至2024年8月19日，当前有6家机构对Fennec Pharmaceuticals Inc.目标价做出预测，其中目标均价为15.83美元，其中最低目标价为14.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900044395a386b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900044395a386b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC"],"gpt_icon":0},{"id":"2459110388","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110388","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110388?lang=zh_cn&edition=full","pubTime":"2024-08-14 22:39","pubTimestamp":1723646359,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日22时39分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速跳水5.21%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为84.58%、70.92%、60.69%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814223919aefec0e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814223919aefec0e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2459110671","title":"美国研究综述-Agenus、Guardant Health、Zoetis","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110671","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110671?lang=zh_cn&edition=full","pubTime":"2024-08-14 14:49","pubTimestamp":1723618162,"startTime":"0","endTime":"0","summary":"    路透8月14日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Agenus、Guardant Health 和 Zoetis。要闻              * Agenus Inc   ：B. Riley将目标价从42美元下调至18美元             * Clorox   ：杰富瑞将目标价从 148 美元上调至 151 美元             * Guardant Health Inc   ：Raymond James将目标价从28美元上调至36美元             * 星巴克  ：Stifel将其评级从 \"持有 \"上调至 \"买入\"；将目标价从80美元上调至110美元             * Zoetis Inc   ：Piper Sandler将目标价从195美元上调至210美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BALL","EIX","IBTA","LU0942090050.USD","ANNX","FTHM","LU1363072403.SGD","AGEN","BOLD","CPK","IDXX","DUK","CNP","ETR","LU2211815571.USD","AMCX","FENC","LU0149725797.USD","MO","HEI","CTNM","ADVM","ATKR","FEMY","ALUR","HD","FE","BHF","CMS","LU2506952410.USD","WTRG","CLX","LU","LU0205193047.USD","AIZ","SKY","ED","EXC","AEP","LU2506952337.HKD","AWK","GH","SLRN","D","EMR","ES","BKH"],"gpt_icon":1},{"id":"2459507901","title":"Fennec Pharmaceuticals Inc.盘中异动 股价大跌13.84%报5.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459507901","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459507901?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:32","pubTimestamp":1723555938,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时32分，Fennec Pharmaceuticals Inc.股票出现波动，股价快速跳水13.84%。截至发稿，该股报5.39美元/股，成交量2.0822万股，换手率0.08%，振幅6.40%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132189f278dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408132132189f278dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0},{"id":"2458543941","title":"Fennec Pharmaceuticals Inc   预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458543941","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458543941?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:25","pubTimestamp":1723231513,"startTime":"0","endTime":"0","summary":"   * Fennec Pharmaceuticals Inc    将于8月13日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的333万美元增长232.3%，达到1104.9万美元。* LSEG 分析师对 Fennec Pharmaceuticals Inc 的平均预期是每股亏损 3 美分。* 华尔街对 Fennec Pharmaceuticals Inc 的 12 个月目标价中位数为 16.50 美元，高于其最新收盘价 6.08 美元。8月9日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Fennec Pharmaceuticals Inc   预计每股亏损 3 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENC"],"gpt_icon":0},{"id":"2457268098","title":"Fennec Pharmaceuticals Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457268098","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457268098?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:37","pubTimestamp":1723045071,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时37分，Fennec Pharmaceuticals Inc.股票出现异动，股价急速拉升5.15%。截至发稿，该股报5.92美元/股，成交量2.4933万股，换手率0.09%，振幅3.55%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.99%。其相关个股中，Aditxt, Inc.、G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为4462.36%、1045.41%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、47.31%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807233751af966bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807233751af966bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FENC"],"gpt_icon":0},{"id":"2457775528","title":"Fennec Pharmaceuticals Inc.盘中异动 早盘急速下跌6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775528","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775528?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:32","pubTimestamp":1722864779,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时32分，Fennec Pharmaceuticals Inc.股票出现波动，股价急速跳水6.07%。截至发稿，该股报5.41美元/股，成交量1099股，换手率0.00%，振幅0.00%。Fennec Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为982.49%、35.53%、13.54%，振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为13.04%、12.19%、11.60%。Fennec Pharmaceuticals Inc.公司简介：Fennec Pharmaceuticals Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521325996823eef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521325996823eef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FENC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fennecpharma.com","stockEarnings":[{"period":"1week","weight":0.0727},{"period":"1month","weight":0.0396},{"period":"3month","weight":-0.1719},{"period":"6month","weight":-0.2955},{"period":"1year","weight":-0.4655},{"period":"ytd","weight":-0.5793}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fennec Pharmaceuticals Inc.最初是作为一家英属哥伦比亚公司成立的，其名称是“粘着”技术公司，随后于2014年9月3日改名。Fennec和它的全资子公司氧化奎特公司(“氧化物”)和Fennec制药公司，以及加拿大的一家加拿大公司(简称“CBI”)，在这里被统称为“公司”，是一家生物制药公司，有一个正在开发中的产品，用于治疗癌症。该公司是一家生物制药公司，主要关注硫代硫酸钠(“STS”)的开发，以预防小儿癌症患者体内铂中毒的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.012234},{"month":2,"riseRate":0.571429,"avgChangeRate":0.018842},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.020679},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.021313},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.031154},{"month":6,"riseRate":0.428571,"avgChangeRate":0.018884},{"month":7,"riseRate":0.714286,"avgChangeRate":0.031531},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.050899},{"month":9,"riseRate":0.571429,"avgChangeRate":0.035762},{"month":10,"riseRate":0.375,"avgChangeRate":-0.005151},{"month":11,"riseRate":0.75,"avgChangeRate":0.008001},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038013}],"exchange":"NASDAQ","name":"Fennec Pharmaceuticals Inc.","nameEN":"Fennec Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fennec Pharmaceuticals Inc.,FENC,Fennec Pharmaceuticals Inc.股票,Fennec Pharmaceuticals Inc.股票老虎,Fennec Pharmaceuticals Inc.股票老虎国际,Fennec Pharmaceuticals Inc.行情,Fennec Pharmaceuticals Inc.股票行情,Fennec Pharmaceuticals Inc.股价,Fennec Pharmaceuticals Inc.股市,Fennec Pharmaceuticals Inc.股票价格,Fennec Pharmaceuticals Inc.股票交易,Fennec Pharmaceuticals Inc.股票购买,Fennec Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fennec Pharmaceuticals Inc.(FENC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fennec Pharmaceuticals Inc.(FENC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况